Join Growin Stock Community!

Medline inc.MDLN.US Overview

US StockHealthcare
(No presentation for MDLN)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

MDLN AI Insights

MDLN Overall Performance

MDLN AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MDLN Recent Performance

-1.10%

Medline inc.

1.63%

Avg of Sector

0.63%

S&P500

MDLN PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

MDLN Key Information

MDLN Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

MDLN Profile

Price of MDLN

MDLN FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MDLN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.62
PE Ratio (TTM)
68.86
Forward PE
29.41
PS Ratio (TTM)
1.36
PB Ratio
312.24
Price-to-FCF
56.90
METRIC
VALUE
vs. INDUSTRY
Gross Margin
25.43%
Net Margin
3.38%
Revenue Growth (YoY)
8.21%
Profit Growth (YoY)
9.57%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.62
PE Ratio (TTM)
68.86
Forward PE
29.41
PS Ratio (TTM)
1.36
PB Ratio
312.24
Price-to-FCF
56.90
Gross Margin
25.43%
Net Margin
3.38%
Revenue Growth (YoY)
8.21%
Profit Growth (YoY)
9.57%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is MDLN's latest earnings report released?

    The most recent financial report for Medline inc. (MDLN) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MDLN's short-term business performance and financial health. For the latest updates on MDLN's earnings releases, visit this page regularly.

  • How much debt does MDLN have?

    As of the end of the reporting period, Medline inc. (MDLN) had total debt of 12.56B, with a debt ratio of 0.33. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does MDLN have?

    At the end of the period, Medline inc. (MDLN) held Total Cash and Cash Equivalents of 1.94B, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does MDLN go with three margins increasing?

    In the latest report, Medline inc. (MDLN) achieved the “three margins increasing” benchmark, with a gross margin of 24.6%%, operating margin of 5.46%%, and net margin of 2.3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MDLN's profit trajectory and future growth potential.